Title

Emerging anabolic treatments for osteoporosis.

Document Type

Article

Publication Date

2001

Keywords

Animal, Drug-Therapy-Combination, Female, Fractures, Human, Insulin-Like-Growth-Factor-I, Male, Middle-Age, Osteoporosis-Postmenopausal, Parathyroid-Hormones, Recombinant-Proteins, Somatropin

JAX Location

see Reprint Collection

JAX Source

Rheum Dis Clin North Am 2001 Feb; 27(1):215-33, viii.

Abstract

Therapy for osteoporosis is principally centered on the use of agents that block bone resorption and supplementation with vitamin D and calcium. Although these drugs are effective in reducing the risk of subsequent fractures, and modestly increasing bone density, most patients being treated for osteoporosis still have low bone mass and a greater risk of fracture. Anabolic agents stimulate bone formation, strength, and mass. In addition, there is emerging evidence that anabolic agents can reduce subsequent fracture risk. The two most promising agents, parathyroid hormone (PTH) and GH/IGF-I, act to increase osteoblast mediated bone formation. A review of the potential usefulness of PTH and GH/IGF-I is presented.

Please contact the Joan Staats Library for information regarding this document.

Share

COinS